Cybersecurity is the practice of protecting a medical device, its software, and its connected systems from unauthorized access, tampering, and disruption across the product lifecycle. In MedTech, it is patient safety control first and technical control second, because a compromised device can deliver incorrect therapy, expose health data, or stop working during care.
What is cybersecurity in medical devices?
Cybersecurity in medical devices covers the people, processes, and technical controls that keep a device trustworthy from design through decommissioning. It applies to any product with software, firmware, or a network interface, including infusion pumps, patient monitors, imaging systems, and Software as a Medical Device (SaMD). The central idea is security by design, meaning threats are identified early, and controls are built into the architecture rather than added after a product ships.
Regulators now frame cybersecurity as part of a device’s safety and effectiveness. A vulnerability that lets an attacker alter a dose or falsify a reading is a safety hazard, so it is managed inside the same quality system that governs the rest of the design.
Why cybersecurity matters in medical device development
Connected devices widen the attack surface, and the consequences land on patients. Ransomware that locks a monitoring station, a spoofed sensor value, or a stolen credential can each translate into clinical harm. That link to patient harm is what gives cybersecurity direct regulatory weight.
In the United States, Section 524B of the FD&C Act, added by the 2022 Omnibus and in force since March 2023, makes cybersecurity information a condition of premarket review for cyber devices. A submission missing the required content can receive a Refuse to Accept (RTA) hold. The commercial stakes are real too: rework late in development, delayed clearance, field patches, and recall exposure all cost far more than building controls in from the start. Auditors and notified bodies expect documented evidence, so weak cybersecurity documentation frequently surfaces during inspections and EU MDR conformity assessments.
How medical device cybersecurity works
Most development programs follow a Secure Product Development Framework (SPDF), which integrates cybersecurity activities throughout the product lifecycle. Typical elements include:
- Threat modeling. Map the device, interfaces, assets, and data flows, then identify potential attack paths. STRIDE-based analysis is widely used.
- Security risk management. Evaluate cybersecurity risks and implement controls using approaches described in AAMI SW96 and AAMI TIR57, while linking cybersecurity risk management to ISO 14971 safety risk management.
- Secure architecture and design. Implement authentication, authorization, encryption, secure boot, secure communications, and least-privilege principles to reduce attack opportunities.
- Software Bill of Materials (SBOM). Maintain an inventory of commercial, open-source, and third-party software components so vulnerabilities can be rapidly identified and managed.
- Verification and security testing. Perform vulnerability scanning, static and dynamic application security testing, fuzz testing, and independent penetration testing against realistic attack scenarios.
- Postmarket monitoring. Continuously monitor emerging vulnerabilities, maintain a coordinated vulnerability disclosure (CVD) process, and release security updates and patches according to documented timelines.
These activities align with recognized standards and guidance, including:
- IEC 62304 for medical device software lifecycle processes.
- IEC 81001-5-1 for secure health software development lifecycle activities.
- ISO 14971 for medical device risk management.
- FDA cybersecurity guidance, which integrates cybersecurity expectations into the Quality Management System Regulation (QMSR) aligned with ISO 13485:2016.
- EU MDR Annex I Sections 17.2 and 17.4, supported by MDCG 2019-16, which require cybersecurity appropriate to the current state of the art.
Common challenges and best practices
The most common mistake is treating cybersecurity as documentation prepared immediately before submission rather than as a design requirement. When security controls are added late, manufacturers often face expensive redesigns, delayed regulatory submissions, and increased validation work.
Incomplete Software Bills of Materials (SBOMs) are another recurring issue. Missing third-party libraries or open-source dependencies make vulnerability management significantly more difficult throughout the device lifecycle.
Legacy and long-life medical devices present additional challenges because they may not support modern security updates. Manufacturers are still expected to implement risk-based vulnerability management and document compensating controls where software updates are impractical.
Successful cybersecurity programs typically:
- Perform threat modeling during system architecture development.
- Maintain an accurate and continuously updated SBOM.
- Conduct independent security testing before market release.
- Operate a formal vulnerability disclosure and patch management program.
- Integrate cybersecurity activities into the ISO 13485 quality management system so every activity is controlled, documented, and traceable.
How SJML helps with cybersecurity
SJML supports medical device cybersecurity through its QARA Compliance-as-a-Service and software regulatory work. Its teams handle SaMD lifecycle activities under IEC 62304 and cybersecurity risk assessments aligned with IEC 81001-5-1, alongside ISO 14971 risk management and ISO 13485 quality management systems. As an organization certified to ISO 27001, SJML applies information security practices throughout its design and manufacturing operations and helps manufacturers align cybersecurity activities with FDA and EU MDR expectations within a controlled quality management system.
Frequently asked questions
Yes. In the United States, Section 524B of the FD&C Act requires cybersecurity documentation for applicable cyber devices submitted to the FDA, and FDA guidance integrates cybersecurity into the Quality Management System Regulation (QMSR). In Europe, EU MDR Annex I Sections 17.2 and 17.4 require manufacturers to implement state-of-the-art cybersecurity measures. Both regulators now treat cybersecurity as an essential component of medical device safety.
A Software Bill of Materials (SBOM) is a structured inventory of every software component used within a medical device, including commercial, open-source, and third-party software. The FDA expects manufacturers to provide an SBOM so affected components can be rapidly identified when new vulnerabilities are disclosed, allowing faster patching and improved vulnerability management throughout the product lifecycle.
The principal standards include:
IEC 81001-5-1 for secure health software lifecycle activities.
IEC 62304 for medical device software development.
ISO 14971 for risk management.
AAMI SW96 and AAMI TIR57 for cybersecurity risk management.
MDCG 2019-16 for EU MDR cybersecurity guidance.
FDA cybersecurity guidance for premarket cybersecurity submissions.
Together, these standards form the current state of the art for medical device cybersecurity.
A Secure Product Development Framework (SPDF) is a structured set of lifecycle processes that integrates cybersecurity into every stage of medical device development rather than treating security as a final validation activity. An SPDF typically includes threat modeling, security risk management, secure architecture, SBOM management, security verification testing, vulnerability disclosure, and postmarket monitoring. The FDA recommends adopting an SPDF to demonstrate systematic cybersecurity management throughout the device lifecycle.
Related terms
- Software as a Medical Device (SaMD)
- IEC 62304
- Software Bill of Materials (SBOM)
- ISO 14971 Risk Management
- Post-Market Surveillance
